Clinical Trial Update: Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial assessing an oral colostrum-derived anti-Clostridioides difficile antibodies for Clostridioides difficile infection has been withdrawn (Phas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clostridioides Difficile Infection

Drugs mentioned

• Colostrum-Derived Anti-Clostridioides difficile Antibodies

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Clostridium Difficile-Associated Diarrhea | Phase 2, Phase 3 | Status: WITHDRAWN